Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
-
AIDS 2020 exhibition: Love, life and riots
News Photo galleryWe’re exhibiting at #AIDS2020Virtual, the world’s largest virtual AIDS conference. Our photo exhibition Love, Life and Riots will be on...
-
What’s on: AIDS 2020 Virtual for treatment activists
NewsKicking off on Monday 6 July, with a workshop on innovative strategies to reduce prohibitive drug prices, we’ve compiled some...
Read more about What’s on: AIDS 2020 Virtual for treatment activists
-
Ukraine: 100% LIFE opposes patent on TB drug for children
NewsOur campaign partner in Ukraine, 100% LIFE, has submitted the first patent opposition on bedaquiline in the Eastern Europe and Central...
Read more about Ukraine: 100% LIFE opposes patent on TB drug for children
-
“Women must be able to decide what they want – for themselves”
InterviewYupa, 46, from Lamphun, Thailand, is advocating for women to have more choices and control over their own sexual and...
Read more about “Women must be able to decide what they want – for themselves”
-
Argentina: Fundación GEP opposes Gilead’s patent application on remdesivir
Call to action NewsOur partner, Fundación GEP, has filed a patent opposition against Gilead’s patent application on remdesivir before the Argentinean Patent Office....
Read more about Argentina: Fundación GEP opposes Gilead’s patent application on remdesivir
-
COVID-19: Local manufacturing essential if we are to “treat all”
NewsITPC led a virtual roundtable last week (26 May 2020) attended by civil society treatment experts, researchers, and national pharmaceutical...
Read more about COVID-19: Local manufacturing essential if we are to “treat all”
-
Jeed: HIV treatment was like winning the lottery
Interview“I was diagnosed with HIV at 21, in 1995. Treatment wasn’t available in Thailand at the time, all they could...
Read more about Jeed: HIV treatment was like winning the lottery
-
“Children are suffering side-effects from sub-standard HIV treatment”
InterviewThe longer that HIV antiretroviral drugs (ARVs) have been around, the more that is being discovered about long-term side-effects. In...
Read more about “Children are suffering side-effects from sub-standard HIV treatment”
-
Moroccan civil society calls for compulsory licence on Gilead’s possible COVID-19 drug
NewsOn 12 May 2020, Gilead Sciences announced voluntary licenses to five generic manufacturers in India and Pakistan allowing them to...
-
Brazil and Thailand: Activists oppose more TB patents during COVID-19 pandemic
NewsBedaquiline (BDQ) is a core component of an ‘all-oral’ solution to multi-drug resistant TB (MDR-TB), and is recommended by the...
Read more about Brazil and Thailand: Activists oppose more TB patents during COVID-19 pandemic
